Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Cytopathological Significance of Intracytoplasmic Lumina and Immunohistochemical Mucin Expression in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder.

Diagnostic cytopathology·2026
Same author

Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.

Nature·2026
Same author

A scalable two-step genome editing strategy for generating full-length gene-humanized mice at diverse genomic loci.

Nature communications·2026
Same author

Functional and structural analysis of KK-LC-1-specific T cell receptors from patients with lung Cancer for immunotherapy.

Cellular immunology·2026
Same author

Successful Treatment of Acquired von Willebrand Syndrome in a Rare Case of Nodal Marginal Zone Lymphoma With Rituximab Therapy: A Case Report.

Cureus·2025
Same author

Efficacy of additional tissue sections for diminutive colorectal adenomas pathologically diagnosed as normal mucosa: a retrospective, cross-sectional study in Japan.

Clinical endoscopy·2025

Related Experiment Video

Updated: Jul 6, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Virtual screening system for finding structurally diverse hits by active learning.

Yukiko Fujiwara1, Yoshiko Yamashita, Tsutomu Osoda

  • 1Service Platform Laboratories, NEC Corporation, 2-11-5, Shibaura, Minato-ku, Tokyo 108-8557, Japan. y-fujiwara@db.jp.nec.com

Journal of Chemical Information and Modeling
|March 21, 2008
PubMed
Summary

New virtual screening methods, query by bagging (QBag) and descriptor-sampling (QBagDS), improve drug discovery by identifying more diverse and potent compounds. These active learning strategies outperform traditional methods in finding novel drug candidates.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
06:29

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

Related Experiment Videos

Last Updated: Jul 6, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
06:29

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

Area of Science:

  • Computational chemistry
  • Cheminformatics
  • Drug discovery

Background:

  • Virtual screening is crucial for identifying potential drug candidates.
  • Traditional similarity-based methods can be limited in finding structurally diverse compounds.
  • Active learning strategies offer a promising approach to enhance virtual screening efficiency.

Purpose of the Study:

  • To develop and evaluate novel virtual screening strategies based on active learning.
  • To compare the performance of "query by bagging" (QBag) and "query by bagging with descriptor-sampling" (QBagDS) against conventional methods.
  • To assess the impact of descriptor sampling and prior knowledge on hit identification.

Main Methods:

  • Devised two active learning-based virtual screening strategies: QBag and QBagDS.
  • QBag generates multiple structure-activity relationship rules via bagging and iteratively selects compounds.
  • QBagDS incorporates descriptor sampling to enhance structural diversity of identified hits.

Main Results:

  • Simulation experiments and clustering analysis demonstrated that QBag and QBagDS outperform similarity-based screening.
  • The combination of descriptor sampling and prior knowledge significantly improved the identification of numerous hits.
  • Application of QBagDS to novel hit finding resulted in 4 out of 10 selected compounds exhibiting high inhibition.

Conclusions:

  • QBag and QBagDS are effective virtual screening strategies for identifying diverse and potent drug candidates.
  • Descriptor sampling and prior knowledge integration are key factors for maximizing hit discovery.
  • These advanced methods show significant potential for accelerating novel drug discovery pipelines.